| Entry |
|
| Name |
Carperitide (USAN/INN); Carperitide (genetical recombination) (JAN); Hanp (TN) |
| Formula |
C127H203N45O39S3
|
| Exact mass |
3078.4447
|
| Mol weight |
3080.45
|
| Structure |

|
| Sequence |
Ser Leu Arg Arg Ser Ser Cys Phe Gly Gly Arg Met Asp Arg Ile Gly Ala Gln Ser Gly Leu Gly Cys Asn Ser Phe Arg Tyr (Disulfide bridge: 7-23) |
| Type |
Peptide |
| Remark |
| Therapeutic category: | 2179 |
|
| Efficacy |
Vasodilator, Atrial natriuretic peptide receptor agonist |
| Comment |
Recombinant of human alpha atrial natriuretic polypeptide (ANP) [HSA: 4878]
|
| Target |
|
| Pathway |
| hsa04270 | Vascular smooth muscle contraction |
|
| Interaction |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
217 Vasodilators
2179 Others
D03328 Carperitide (USAN/INN); Carperitide (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
Other
NPR1
D03328 Carperitide (USAN/INN) <JP>
|
| Other DBs |
|
| LinkDB |
|